Cervical cancer remains the leading cause of cancer death for women in many low to middle income countries—despite the fact that reliable prevention and treatment options exist. But major breakthroughs in diagnostics and a new vaccine could allow for great gains in reducing cervical cancer rates in the global South.
- At-home HPV tests are “poised to be a game-changer” to reach women who have never been screened for HPV or cervical cancer due to geographic or social barriers.
- A new HPV vaccine approved by WHO may alleviate global vaccine supply issues, bringing more options to underserved regions.
- Artificial intelligence could revolutionize the screening process for cervical and breast cancer. and cost of cervical cancer screening in low-income communities.